CIK 0001559053
- Accelerated filer
PROTHENA CORP PUBLIC LTD CO
Sign in to watch- Ticker
- PRTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- Operating
- Phone
- +353 12362500
- Business address
- 77 SIR JOHN ROGERSON'S QUAY, BLOCK C, GRAND CANAL DOCKLANDS, DUBLIN 2, Ireland, D02 VK60
- Former names
- Prothena Corp plc, Neotope Corp Ltd
- Open-market buys, last 90 days
- $9,813,971
- in 10 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,813,971. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-09-13 | Smith Brandon S. Chief Operating Officer | Sale 10b5-1 | −3,886 | $55.48 | $216K | 114 |
| 2023-09-13 | Smith Brandon S. Chief Operating Officer | Sale 10b5-1 | −114 | $55.96 | $6K | 0 |
| 2023-09-06 | Karp Carol D. Chief Regulatory Officer | Sale 10b5-1 | −4,994 | $54.76 | $273K | 6 |
| 2023-09-06 | Karp Carol D. Chief Regulatory Officer | Sale 10b5-1 | −6 | $55.27 | $332 | 0 |
| 2023-08-30 | Malecek Michael J Chief Legal Officer | Sale 10b5-1 | −2,322 | $54.58 | $127K | 2,678 |
| 2023-08-30 | Malecek Michael J Chief Legal Officer | Sale 10b5-1 | −2,664 | $55.39 | $148K | 14 |
| 2023-08-30 | Malecek Michael J Chief Legal Officer | Sale 10b5-1 | −14 | $56.21 | $787 | 0 |
| 2023-08-18 | Walker Karin L Chief Accounting Officer | Sale 10b5-1 | −5,000 | $57.18 | $286K | 0 |
| 2023-08-16 | Garren Hideki Chief Medical Officer | Sale 10b5-1 | −878 | $58.15 | $51K | 1,122 |
| 2023-08-16 | Garren Hideki Chief Medical Officer | Sale 10b5-1 | −748 | $58.93 | $44K | 374 |
| 2023-08-16 | Garren Hideki Chief Medical Officer | Sale 10b5-1 | −374 | $59.74 | $22K | 0 |
| 2023-08-16 | Smith Brandon S. Chief Operating Officer | Sale 10b5-1 | −2,226 | $58.22 | $130K | 1,774 |
| 2023-08-16 | Smith Brandon S. Chief Operating Officer | Sale 10b5-1 | −1,373 | $59.15 | $81K | 401 |
| 2023-08-16 | Smith Brandon S. Chief Operating Officer | Sale 10b5-1 | −401 | $59.91 | $24K | 0 |
| 2023-08-02 | Zago Wagner M. Chief Scientific Officer | Sale 10b5-1 | −3,771 | $66.98 | $253K | 229 |
| 2023-08-02 | Zago Wagner M. Chief Scientific Officer | Sale 10b5-1 | −229 | $68.07 | $16K | 0 |
| 2023-08-02 | Karp Carol D. Chief Regulatory Officer | Sale 10b5-1 | −4,672 | $66.95 | $313K | 328 |
| 2023-08-02 | Karp Carol D. Chief Regulatory Officer | Sale 10b5-1 | −328 | $67.95 | $22K | 0 |
| 2023-07-26 | Malecek Michael J Chief Legal Officer | Sale 10b5-1 | −2,477 | $61.78 | $153K | 2,523 |
| 2023-07-26 | Malecek Michael J Chief Legal Officer | Sale 10b5-1 | −1,903 | $62.69 | $119K | 620 |
Page 2 of 15 · 284 trades